Advertisement

Interferon alpha 2-b therapy of HCV and NonBNonC chronic hepatitis

  • M. Gargiulo
  • P. Tarquini
  • L. Di Ottavio
  • E. Lattanzi
  • A. De Nigris-Urbani
Part of the Archives of Virology book series (ARCHIVES SUPPL, volume 4)

Summary

Twenty-four patients with HCV and NonBNonC chronic hepatitis—4 with HIV coinfection—were treated with r-IFN alpha for at least six months. In this period 62.5% of patients show a normalization of ALT but not a sustained remission. Non-responders have histologically more severe and long-lasting chronic hepatitis.

Keywords

Chronic Hepatitis Sustained Remission Patient Risk Factor Alpha Interferon Therapy Recombinant Interferon Alpha 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Davis GL, Baiart LA, Schiff ER et al (1989) Treatment of chronic hepatitis C with recombinant interferon alpha. A multicentric randomized controlled trial. N Engl J Med 22: 1501–1505Google Scholar
  2. 2.
    Di Bisceglie AM, Martin P, Kassianides C et al (1989) Recombinant alpha interferon therapy for chronic hepatitis C. N Engl J Med 22: 1506–1510CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • M. Gargiulo
    • 1
  • P. Tarquini
    • 1
  • L. Di Ottavio
    • 1
  • E. Lattanzi
    • 2
  • A. De Nigris-Urbani
    • 2
  1. 1.Sezione Malattie InfettiveOspedale Civile “G. Mazzini”TeramoItaly
  2. 2.Servizio Trasfusionale e di ImmunoematologiaOspedale Civile “G. Mazzini”TeramoItaly

Personalised recommendations